Natural aminosterols inhibit NMDA receptors with low nanomolar potency
The FEBS Journal · 2025
DOI: 10.1111/febs.70072 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, 2025. Verfasst von Giulia Fani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Biomedical Sciences, Section of Biochemistry, University of Florence, Italy. Hauptthemen laut MEDLINE: Receptors, N-Methyl-D-Aspartate. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Firenze, Regione Toscana, Ministero dell'Università e della Ricerca.
Abstract (Originalsprache)
Abnormal functions of N‐methyl‐D‐aspartate receptors (NMDARs) are associated with many brain disorders, making them primary targets for drug discovery. We show that natural aminosterols inhibit the NMDAR‐mediated increase of intracellular calcium ions in cultured primary neurons and neuroblastoma cells. Structural comparison with known NMDAR‐negative allosteric modulators, such as pregnanolone‐sulfate‐2 (PAS), raises the hypothesis that aminosterols have the same mechanism of action. Fluorescence resonance energy transfer (FRET) measurements using labeled NMDAR and the labeled aminosterol trodusquemine (TRO) indicate close spatial proximity, likely arising from binding. Other indirect yet plausible mechanisms for NMDAR inhibition by TRO were excluded. Electrophysiological patch clamp measurements on primary neurons indicate that pre‐incubated TRO inhibits NMDA‐induced ion currents with a IC 50 of 5 n m . Inhibition is observed only after cell membrane pre‐adsorption, indicating accessibility to NMDAR from the cell membrane and binding to the transmembrane domains (TMDs) and TMD‐ligand‐binding domain (LBD) linkers, similarly to PAS. The TRO IC 50 is 5000‐fold higher than that of PAS and 20–16 000 times higher than those of other inhibitors binding to TMD/TMD‐LBD regions, identifying aminosterols as promising and potent NMDAR modulators.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Experimental and Clinical Biomedical Sciences, Section of Biochemistry, University of Florence, Italy.
- Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), Division of Pharmacology and Toxicology, University of Florence, Italy.
- Centre for Misfolding Diseases, Yusuf Hamied Department of Chemistry, University of Cambridge, UK.
- Enterin Research Institute Inc., Philadelphia, PA, USA.
- MedStar-Georgetown Transplant Institute, Georgetown University School of Medicine, Washington, DC, USA.
ORCID-Profile: Michele Vendruscolo, Fabrizio Chiti
Förderung
- Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Firenze
- Regione Toscana
- Ministero dell'Università e della Ricerca
- Progetto Dipartimenti di Eccellenza 2022-2027
Zitieren
APA
Fani, G., Coppi, E., Errico, S., Cherchi, F., Gennari, M., Barbut, D., Vendruscolo, M., Zasloff, M., Pugliese, A. M., & Chiti, F. (2025). Natural aminosterols inhibit NMDA receptors with low nanomolar potency. The FEBS Journal. https://doi.org/10.1111/febs.70072
Vancouver
Fani G, Coppi E, Errico S, Cherchi F, Gennari M, Barbut D, et al. Natural aminosterols inhibit NMDA receptors with low nanomolar potency. The FEBS Journal. 2025. doi:10.1111/febs.70072
BibTeX
@article{Fani2025,
author = {Fani, Giulia and Coppi, Elisabetta and Errico, Silvia and Cherchi, Federica and Gennari, Martina and Barbut, Denise and Vendruscolo, Michele and Zasloff, Michael and Pugliese, Anna Maria and Chiti, Fabrizio},
title = {Natural aminosterols inhibit NMDA receptors with low nanomolar potency},
journal = {The FEBS Journal},
year = {2025},
doi = {10.1111/febs.70072}
}
EUVIMED